Rebecca is a publishing professional who has over 40 years of experience in all aspects of scientific, technical, and medical publishing—book, journals, periodicals, and online. She is the former Publisher of American Psychiatric Publishing, a division of the American Psychiatric Association, and the world’s leading publisher of books, journals, periodicals, and online resources on psychiatry, mental health, and behavioral science. In this position, she managed acquisitions and new product development, peer review, marketing, editorial, production, rights, and distribution for print and online products, most notably the international publication of the Diagnostic and Statistic Manual of Psychiatric Disorders, Fifth Edition (DSM-5).
Previously Rebecca served as Senior Director and Publisher at The Endocrine Society overseeing the publication of its four scientific journals, three periodicals, books and CME programs, and Endocrine News. In this position she launched a book program and two new periodicals as well as an online news feature.
Rebecca started her career at Harper & Row Publishers, where she held various production, editorial, and management positions before serving as Senior Medical Editor for acquisitions. She then joined The American College of Obstetricians and Gynecologists to develop a publishing program of books, periodicals, and consumer literature that included the journal, Obstetrics & Gynecology.
Mark has spent the last 30 years in scholarly and b2b publishing, specialising in delivering product and portfolio growth in challenging and changing markets. Most recently, he has been focused on finding solutions to the challenges of open access in the scholarly publishing market. He was the OA lead at IOP Publishing where he was responsible for bringing open access right into the heart of the organisation. He has experience in a very broad range of open access business models, including consortial models like SCOAP3 and transformative agreements. He launched a new portfolio of fully gold OA journals at IOP and also played a major role in developing IOP’s open access and open data policies.
He started his career at Elsevier editing scientific journals and managing peer review before spending more than 15 years helping to build Elsevier’s magazine and newsletter publishing division during the transition to digital publication. His expertise lies in enabling teams to produce high quality and profitable editorial products that meet the needs of their customers, whether those customers are researchers, readers, editors, societies, librarians or funders. He relishes finding practical solutions to challenging problems and has worked with staff, customers and partners from every corner of the world.
Alina is an experienced Managing Director who has worked across a variety of publishing sectors from medical and academic to legal and professional markets. Adept at setting strategy and commercial direction, she has led teams ranging from 20 – 100 and has driven change, digital transformation, and revenue and profit growth. With over 20 years of senior leadership experience, Alina has held significant operational roles in the profit and not-for-profit with a particular focus on digital transformation, most recently as Managing Director of the publishing arm of the Royal Pharmaceutical Society – and previously, as Digital Business Director for the UK Legal division of Thomson Reuters.
From her various roles, she has experience of a wide range of publishing and business models, from print to digital, including print and online journals and magazines. Business model experience includes subscription, licensing, digital advertising and sponsorship. Working with a range of Government departments and large international corporates in the legal, pharmaceutical and health sectors, Alina has also negotiated large contracts with Government departments, particularly the NHS. Over the last six years Alina has taken on several Board positions. Working as a Non-Executive Director, Chair and Advisor to the Board, her skills lie in being able to respect a variety of stakeholder views while achieving agreement through clarifying issues, advocating solutions and facilitating decision-making. Current Board commitments include the Royal Society of Chemistry; Manchester University Press; the Institute of Engineering and Technology; the Royal Pharmaceutical Society; and Thrive – the Horticultural Therapy Charity.